Patient Capital Management’s Expedia Group EXPE Stock Holding History

Patient Capital Management's EXPE Position: Q2 2026 in Review

Patient Capital Management increased its Expedia Group (EXPE) stake by 0.02% in Q2 2026, buying an estimated $7.13K and bringing the position to 167,814 shares worth $42.9M. The position accounts for 1.41% of the portfolio, ranked #27.

Patient Capital Management first reported a position in EXPE in Q2 2022 and has held it in 17 quarters since. The position peaked at $142M in Q4 2023. 1,125 funds tracked by Wall St. Rank hold EXPE as of Q2 2026.

• Patient Capital Management held 167,814 shares of Expedia Group worth $42.9M as of Q2 2026.
• Patient Capital Management bought 30 Expedia Group shares in Q2 2026, an estimated $7.13K.
• Expedia Group made up 1.41% of Patient Capital Management's portfolio in Q2 2026, its #27 holding.
• Patient Capital Management first reported a position in Expedia Group in Q2 2022 and has held it in 17 quarters since.
• Patient Capital Management's Expedia Group position peaked at $142M in Q4 2023.
• 1,125 funds tracked by Wall St. Rank held Expedia Group as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.